{"id":"325809433036-15","name":"Ludwig Boltzmann Institut f√ºr Health Technology Assessment","registrationDate":"2018-10-29T15:20:10.679+01:00","category":4,"subCategory":5,"legal":"Ludwig Boltzmann Gesellschaft GmbH","web":"http://hta.lbg.ac.at","country":"Austria","headAddress":"Garnisongasse 7/20","headCity":"Wien","headPostCode":"1090","headPhone":"(43)1 -2 36 81 19 -0","boss":"Claudia Wild","bossTitle":"Ms","bossPosition":"Director","membersCount":3,"membersFTE":"3.0","membership":"","memberOrga":"keine Mitgliedsorganisationen bei LBI-HTA","goal":"The LBI-HTA is an independent entity for scientific decision-support in the health sector. We provide the scientific basis for decisions in favor of an efficient and appropriate use of resources. The methodology used is health technology assessment (HTA): HTA refers to the systematic evaluation of properties, effects, and/or impacts of health technology. It is a multidisciplinary process to evaluate the social, economic, organizational and ethical issues of a health intervention or health technology. The main purpose of conducting an assessment is to inform a policy decision making.","acronym":"LBI-HTA","interests":"Fraud prevention, Public Health","euInitiatives":"implementation on HTA in Europe (EUnetHA 2020+): EC-proposal&#xd;<br />implementation of regulations: MDR and IVDR","lastUp":"2018-10-29T15:21:10.690+01:00","customers":"","costAbsolu":"","costRange":"100000-199999","turnoverAbsolu":0,"turnoverRange":""}